Latin America Digital Therapeutics Market Size & Outlook
Latin America digital therapeutics market, 2018-2030 (US$M)
Related Markets
Latin America digital therapeutics market highlights
- The Latin America digital therapeutics market generated a revenue of USD 369.9 million in 2023.
- The market is expected to grow at a CAGR of 28.2% from 2024 to 2030.
- In terms of segment, diabetes was the largest revenue generating application in 2023.
- Diabetes is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, Brazil is expected to register the highest CAGR from 2024 to 2030.
Latin America data book summary
| Market revenue in 2023 | USD 369.9 million |
| Market revenue in 2030 | USD 2,110.0 million |
| Growth rate | 28.2% (CAGR from 2023 to 2030) |
| Largest segment | Diabetes |
| Fastest growing segment | Diabetes |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diabetes, Obesity, CVD, Respiratory Diseases, Smoking Cessation, CNS Diseases |
| Key market players worldwide | Omega Healthcare Investors Inc, Teladoc Health Inc, ResMed Inc, Fitbit, Mango Health, Akili Inc Ordinary Shares, Hygeia Healthcare Holdings Co Ltd Ordinary Shares, DarioHealth Corp, BioGaia AB Class B |
Other key industry trends
- In terms of revenue, Latin America region accounted for 5.9% of the global digital therapeutics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 7,671.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Digital Therapeutics Market Scope
Digital Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America digital therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital therapeutics market will help companies and investors design strategic landscapes.
Diabetes was the largest segment with a revenue share of 30.44% in 2023. Horizon Databook has segmented the Latin America digital therapeutics market based on diabetes, obesity, cvd, respiratory diseases, smoking cessation, cns diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America’s digital therapeutics market is expected to register growth owing to rapid technological advancements and increasing digitalization. This can be attributed to various factors, such as increase in healthcare awareness and availability of technically advanced procedures for diagnosis & treatment of fatal diseases.
The increasing penetration of internet has also led to growing use of e-prescribing systems in the region. Latin America has a combination of large healthcare-oriented human resources and a pool of technical entrepreneurs, which act as a driving factor for market growth.
Reasons to subscribe to Latin America digital therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America digital therapeutics market databook
-
Our clientele includes a mix of digital therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America digital therapeutics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America digital therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America digital therapeutics market size, by country, 2018-2030 (US$M)
Latin America Digital Therapeutics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
